annual total liabilities:
$269.86M-$2.43M(-0.89%)Summary
- As of today (September 15, 2025), AKBA annual total liabilities is $269.86 million, with the most recent change of -$2.43 million (-0.89%) on December 31, 2024.
- During the last 3 years, AKBA annual total liabilities has fallen by -$185.48 million (-40.74%).
- AKBA annual total liabilities is now -43.00% below its all-time high of $473.39 million, reached on December 31, 2018.
Performance
AKBA Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$316.37M+$30.77M(+10.77%)Summary
- As of today (September 15, 2025), AKBA quarterly total liabilities is $316.37 million, with the most recent change of +$30.77 million (+10.77%) on June 1, 2025.
- Over the past year, AKBA quarterly total liabilities has increased by +$62.42 million (+24.58%).
- AKBA quarterly total liabilities is now -37.87% below its all-time high of $509.24 million, reached on March 31, 2022.
Performance
AKBA quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AKBA Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | +24.6% |
| 3 y3 years | -40.7% | -31.1% |
| 5 y5 years | -28.3% | -15.6% |
AKBA Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.7% | at low | -31.1% | +25.2% |
| 5 y | 5-year | -40.7% | at low | -37.9% | +25.2% |
| alltime | all time | -43.0% | >+9999.0% | -37.9% | +6483.4% |
AKBA Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $316.37M(+10.8%) |
| Mar 2025 | - | $285.60M(+5.8%) |
| Dec 2024 | $269.86M(-0.9%) | $269.86M(+4.8%) |
| Sep 2024 | - | $257.54M(+1.4%) |
| Jun 2024 | - | $253.95M(+0.5%) |
| Mar 2024 | - | $252.74M(-7.2%) |
| Dec 2023 | $272.29M(-22.4%) | $272.29M(-0.8%) |
| Sep 2023 | - | $274.42M(-2.2%) |
| Jun 2023 | - | $280.52M(-3.7%) |
| Mar 2023 | - | $291.21M(-17.0%) |
| Dec 2022 | $350.82M(-23.0%) | $350.82M(-16.9%) |
| Sep 2022 | - | $422.04M(-8.2%) |
| Jun 2022 | - | $459.50M(-9.8%) |
| Mar 2022 | - | $509.24M(+11.8%) |
| Dec 2021 | $455.34M(+14.8%) | $455.34M(-2.1%) |
| Sep 2021 | - | $465.12M(+6.4%) |
| Jun 2021 | - | $437.23M(+5.4%) |
| Mar 2021 | - | $414.81M(+4.6%) |
| Dec 2020 | $396.52M(+5.3%) | $396.52M(+10.7%) |
| Sep 2020 | - | $358.18M(-4.5%) |
| Jun 2020 | - | $374.91M(-4.2%) |
| Mar 2020 | - | $391.36M(+4.0%) |
| Dec 2019 | $376.44M | $376.44M(+14.9%) |
| Sep 2019 | - | $327.66M(+7.7%) |
| Jun 2019 | - | $304.17M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $324.41M(-31.5%) |
| Dec 2018 | $473.39M(+95.7%) | $473.39M(+81.2%) |
| Sep 2018 | - | $261.29M(+5.4%) |
| Jun 2018 | - | $247.86M(+0.9%) |
| Mar 2018 | - | $245.62M(+1.6%) |
| Dec 2017 | $241.85M(+4.2%) | $241.85M(+1.3%) |
| Sep 2017 | - | $238.71M(-14.7%) |
| Jun 2017 | - | $279.82M(+22.4%) |
| Mar 2017 | - | $228.64M(-1.5%) |
| Dec 2016 | $232.10M(+1843.5%) | $232.10M(+239.3%) |
| Sep 2016 | - | $68.41M(+9.7%) |
| Jun 2016 | - | $62.35M(+16.2%) |
| Mar 2016 | - | $53.68M(+349.5%) |
| Dec 2015 | $11.94M(+72.6%) | $11.94M(-15.8%) |
| Sep 2015 | - | $14.18M(+139.7%) |
| Jun 2015 | - | $5.91M(-33.2%) |
| Mar 2015 | - | $8.85M(+27.9%) |
| Dec 2014 | $6.92M(+76.9%) | $6.92M(+5.5%) |
| Sep 2014 | - | $6.56M(+36.4%) |
| Jun 2014 | - | $4.81M(-22.0%) |
| Mar 2014 | - | $6.16M(-96.2%) |
| Dec 2013 | $3.91M(-20.6%) | $161.74M(+3185.1%) |
| Dec 2012 | $4.92M(+170.9%) | - |
| Dec 2012 | - | $4.92M |
| Dec 2011 | $1.82M | - |
FAQ
- What is Akebia Therapeutics, Inc. annual total liabilities?
- What is the all time high annual total liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly total liabilities?
- What is the all time high quarterly total liabilities for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Akebia Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of AKBA is $269.86M
What is the all time high annual total liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual total liabilities is $473.39M
What is Akebia Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, AKBA annual total liabilities has changed by -$2.43M (-0.89%)
What is Akebia Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of AKBA is $316.37M
What is the all time high quarterly total liabilities for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly total liabilities is $509.24M
What is Akebia Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, AKBA quarterly total liabilities has changed by +$62.42M (+24.58%)